Literature DB >> 29048952

Increasing availability of illicit and prescription opioids among people who inject drugs in a Canadian setting, 2010-2014.

Joel Ho1, Kora DeBeck2,3, M-J Milloy2,4, Huiru Dong2,5, Evan Wood2,4, Thomas Kerr2,4, Kanna Hayashi2,6.   

Abstract

BACKGROUND: Nonmedical use of prescription opioid and illicit opioid has been increasing at an alarming rate in North America over the past decade.
OBJECTIVE: We sought to examine the temporal trends and correlates of the availability of illicit and prescription opioids among people who inject drugs (PWID) in Vancouver, Canada.
METHODS: Data were derived from three prospective cohort studies of PWID in Vancouver between 2010 and 2014. In semiannual interviews, participants reported the availability of five sets of illicit and prescription opioids: (1) heroin; (2) Percocet (oxycodone/acetaminophen), Vicodin (hydrocodone/acetaminophen), or Demerol (meperidine); (3) Dilaudid (hydromorphone); (4) Morphine; (5) oxycontin/OxyNEO (controlled-release oxycodone). We defined perceived availability as immediate (e.g., available within 10 minutes) versus no availability/available after 10 minutes. The trend and correlation of immediate availability were identified by multivariable generalized estimating equations logistic regression.
RESULTS: Among 1584 participants, of which 564 (35.6%) were female, the immediate availability of all illicit and prescribed opioids (except for oxycontin/OxyNEO) increased over time, independent of potential confounders. The Adjusted Odds Ratios of immediate availability associated with every calendar year increase were between 1.09 (95% confidence interval 1.05-1.12) (morphine and Dilaudid) and 1.13 (95% confidence interval 1.09-1.17) (Percocet/Vicodin/Demerol) (all p-values <0.05).
CONCLUSION: The availability of most prescription opioids had continued to increase in recent years among our sample of PWID in Vancouver. Concurrent increases in the availability of heroin were also observed, raising concerns regarding combination of both illicit and prescription opioid use among PWID that could potentially increase the risk of overdose.

Entities:  

Keywords:  Prescribed opioids; availability; illicit opioids; injected drugs

Mesh:

Substances:

Year:  2017        PMID: 29048952      PMCID: PMC5882238          DOI: 10.1080/00952990.2017.1376678

Source DB:  PubMed          Journal:  Am J Drug Alcohol Abuse        ISSN: 0095-2990            Impact factor:   3.829


  39 in total

1.  Patterns of heroin, cocaine, and alcohol abuse during long-term methadone maintenance treatment.

Authors:  Anja Dobler-Mikola; Josef Hättenschwiler; Daniel Meili; Thilo Beck; Edi Böni; Jiri Modestin
Journal:  J Subst Abuse Treat       Date:  2005-12

Review 2.  The effect of methadone maintenance treatment on alcohol consumption: a systematic review.

Authors:  Anita Srivastava; Meldon Kahan; Sue Ross
Journal:  J Subst Abuse Treat       Date:  2007-06-27

3.  How many people in Canada use prescription opioids non-medically in general and street drug using populations?

Authors:  Svetlana Popova; Jayadeep Patra; Satya Mohapatra; Benedikt Fischer; Jürgen Rehm
Journal:  Can J Public Health       Date:  2009 Mar-Apr

4.  'Opioid drought', Canadian-style? Potential implications of the 'natural experiment' of delisting oxycontin in Canada.

Authors:  Benedikt Fischer; Annette Keates
Journal:  Int J Drug Policy       Date:  2012-08-31

5.  Trends in high-dose opioid prescribing in Canada.

Authors:  Tara Gomes; Muhammad M Mamdani; J Michael Paterson; Irfan A Dhalla; David N Juurlink
Journal:  Can Fam Physician       Date:  2014-09       Impact factor: 3.275

6.  Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users.

Authors:  Thomas Kerr; Nadia Fairbairn; Mark Tyndall; David Marsh; Kathy Li; Julio Montaner; Evan Wood
Journal:  Drug Alcohol Depend       Date:  2006-09-07       Impact factor: 4.492

7.  Changes in Canadian heroin supply coinciding with the Australian heroin shortage.

Authors:  Evan Wood; Jo-Anne Stoltz; Kathy Li; Julio S G Montaner; Thomas Kerr
Journal:  Addiction       Date:  2006-05       Impact factor: 6.526

Review 8.  Alcohol use disorders in opioid maintenance therapy: prevalence, clinical correlates and treatment.

Authors:  Michael Soyka
Journal:  Eur Addict Res       Date:  2014-11-19       Impact factor: 3.015

9.  Evaluating methamphetamine use and risks of injection initiation among street youth: the ARYS study.

Authors:  Evan Wood; Jo-Anne Stoltz; Julio S G Montaner; Thomas Kerr
Journal:  Harm Reduct J       Date:  2006-05-24

10.  Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study.

Authors:  Evan Wood; Thomas Kerr; Brandon D L Marshall; Kathy Li; Ruth Zhang; Robert S Hogg; P Richard Harrigan; Julio S G Montaner
Journal:  BMJ       Date:  2009-04-30
View more
  2 in total

1.  Office-based Methadone Prescribing for Opioid Use Disorder: The Canadian Model.

Authors:  Robert A Kleinman; Thomas D Brothers; Marlon Danilewitz; Anees Bahji
Journal:  J Addict Med       Date:  2022-01-11       Impact factor: 4.647

2.  Availability and use of non-prescribed buprenorphine-naloxone in a Canadian setting, 2014-2020.

Authors:  Paxton Bach; Misha Bawa; Cameron Grant; M J Milloy; Kanna Hayashi
Journal:  Int J Drug Policy       Date:  2021-12-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.